161 related articles for article (PubMed ID: 29107689)
1. Semi-synthetic salinomycin analogs exert cytotoxic activity against human colorectal cancer stem cells.
Klose J; Kattner S; Borgström B; Volz C; Schmidt T; Schneider M; Oredsson S; Strand D; Ulrich A
Biochem Biophys Res Commun; 2018 Jan; 495(1):53-59. PubMed ID: 29107689
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer stem cell selectivity of synthetic nanomolar-active salinomycin analogs.
Huang X; Borgström B; Kempengren S; Persson L; Hegardt C; Strand D; Oredsson S
BMC Cancer; 2016 Feb; 16():145. PubMed ID: 26906175
[TBL] [Abstract][Full Text] [Related]
3. Salinomycin inhibits the growth of colorectal carcinoma by targeting tumor stem cells.
Zhang C; Tian Y; Song F; Fu C; Han B; Wang Y
Oncol Rep; 2015 Nov; 34(5):2469-76. PubMed ID: 26352531
[TBL] [Abstract][Full Text] [Related]
4. Biological activity of doubly modified salinomycin analogs - Evaluation in vitro and ex vivo.
Antoszczak M; Urbaniak A; Delgado M; Maj E; Borgström B; Wietrzyk J; Huczyński A; Yuan Y; Chambers TC; Strand D
Eur J Med Chem; 2018 Aug; 156():510-523. PubMed ID: 30025346
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive review of salinomycin derivatives as potent anticancer and anti-CSCs agents.
Antoszczak M
Eur J Med Chem; 2019 Mar; 166():48-64. PubMed ID: 30684870
[TBL] [Abstract][Full Text] [Related]
6. Semisynthesis of SY-1 for investigation of breast cancer stem cell selectivity of C-ring-modified salinomycin analogues.
Huang X; Borgström B; Månsson L; Persson L; Oredsson S; Hegardt C; Strand D
ACS Chem Biol; 2014 Jul; 9(7):1587-94. PubMed ID: 24841425
[TBL] [Abstract][Full Text] [Related]
7. Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species.
Zhou J; Li P; Xue X; He S; Kuang Y; Zhao H; Chen S; Zhi Q; Guo X
Toxicol Lett; 2013 Oct; 222(2):139-45. PubMed ID: 23916687
[TBL] [Abstract][Full Text] [Related]
8. Synthetic modification of salinomycin: selective O-acylation and biological evaluation.
Borgström B; Huang X; Pošta M; Hegardt C; Oredsson S; Strand D
Chem Commun (Camb); 2013 Nov; 49(85):9944-6. PubMed ID: 24037337
[TBL] [Abstract][Full Text] [Related]
9. Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models.
Urbaniak A; Reed MR; Fil D; Moorjani A; Heflin S; Antoszczak M; Sulik M; Huczyński A; Kupsik M; Eoff RL; MacNicol MC; Chambers TC; MacNicol AM
Biomed Pharmacother; 2021 Sep; 141():111815. PubMed ID: 34130123
[TBL] [Abstract][Full Text] [Related]
10. Salinomycin inhibits metastatic colorectal cancer growth and interferes with Wnt/β-catenin signaling in CD133
Klose J; Eissele J; Volz C; Schmitt S; Ritter A; Ying S; Schmidt T; Heger U; Schneider M; Ulrich A
BMC Cancer; 2016 Nov; 16(1):896. PubMed ID: 27855654
[TBL] [Abstract][Full Text] [Related]
11. Salinomycin selectively targets 'CD133+' cell subpopulations and decreases malignant traits in colorectal cancer lines.
Dong TT; Zhou HM; Wang LL; Feng B; Lv B; Zheng MH
Ann Surg Oncol; 2011 Jun; 18(6):1797-804. PubMed ID: 21267784
[TBL] [Abstract][Full Text] [Related]
12. Salinomycin: Anti-tumor activity in a pre-clinical colorectal cancer model.
Klose J; Trefz S; Wagner T; Steffen L; Preißendörfer Charrier A; Radhakrishnan P; Volz C; Schmidt T; Ulrich A; Dieter SM; Ball C; Glimm H; Schneider M
PLoS One; 2019; 14(2):e0211916. PubMed ID: 30763370
[TBL] [Abstract][Full Text] [Related]
13. The inhibitory effect of salinomycin on the proliferation, migration and invasion of human endometrial cancer stem-like cells.
Kusunoki S; Kato K; Tabu K; Inagaki T; Okabe H; Kaneda H; Suga S; Terao Y; Taga T; Takeda S
Gynecol Oncol; 2013 Jun; 129(3):598-605. PubMed ID: 23500085
[TBL] [Abstract][Full Text] [Related]
14. The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor.
Riccioni R; Dupuis ML; Bernabei M; Petrucci E; Pasquini L; Mariani G; Cianfriglia M; Testa U
Blood Cells Mol Dis; 2010 Jun; 45(1):86-92. PubMed ID: 20444629
[TBL] [Abstract][Full Text] [Related]
15. Salinomycin effectively eliminates cancer stem-like cells and obviates hepatic metastasis in uveal melanoma.
Zhou J; Liu S; Wang Y; Dai W; Zou H; Wang S; Zhang J; Pan J
Mol Cancer; 2019 Nov; 18(1):159. PubMed ID: 31718679
[TBL] [Abstract][Full Text] [Related]
16. Salinomycin inhibits growth of pancreatic cancer and cancer cell migration by disruption of actin stress fiber integrity.
Schenk M; Aykut B; Teske C; Giese NA; Weitz J; Welsch T
Cancer Lett; 2015 Mar; 358(2):161-169. PubMed ID: 25529011
[TBL] [Abstract][Full Text] [Related]
17. Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells.
Fuchs D; Heinold A; Opelz G; Daniel V; Naujokat C
Biochem Biophys Res Commun; 2009 Dec; 390(3):743-9. PubMed ID: 19835841
[TBL] [Abstract][Full Text] [Related]
18. Impact of Salinomycin on human cholangiocarcinoma: induction of apoptosis and impairment of tumor cell proliferation in vitro.
Lieke T; Ramackers W; Bergmann S; Klempnauer J; Winkler M; Klose J
BMC Cancer; 2012 Oct; 12():466. PubMed ID: 23057720
[TBL] [Abstract][Full Text] [Related]
19. Salinomycin and dichloroacetate synergistically inhibit Lewis lung carcinoma cell proliferation, tumor growth and metastasis.
Skeberdytė A; Sarapinienė I; Krasko JA; Barakauskienė A; Žilionytė K; Prokarenkaitė R; Sužiedėlis K; Bukelskienė V; Jarmalaitė S
Biochem Biophys Res Commun; 2020 Mar; 523(4):874-879. PubMed ID: 31955885
[TBL] [Abstract][Full Text] [Related]
20. Co-Eradication of Breast Cancer Cells and Cancer Stem Cells by Cross-Linked Multilamellar Liposomes Enhances Tumor Treatment.
Kim YJ; Liu Y; Li S; Rohrs J; Zhang R; Zhang X; Wang P
Mol Pharm; 2015 Aug; 12(8):2811-22. PubMed ID: 26098197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]